TP53 and pituitary tumor: We propose to delineate all differentiated pituitary tumors with a Ki67 index of more than 50% and the presence of p53 mutation as PitNET G3, as most of these develop metastases, and the undifferentiated/poorly differentiated tumors as PitNEC.